Paper36770656
Coronavirus Inhibitors Targeting nsp16.
Omer EA and 5 others. Molecules, 2023. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Coronavirus Inhibitors Targeting nsp16. Papers, record 36770656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36770656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Middle East Respiratory Syndrome Coronavirus | Major topic |
| Humans | |
| SARS-CoV-2 | |
| Molecular Docking Simulation | |
| S-Adenosylmethionine |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9233431 | The molecular biology of coronaviruses. | Adv Virus Res | 1997 | https://conductscience.org/library/papers/9233431 | PubMed |
| 2 | 21085181 | 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. | Nature | 2010 | https://conductscience.org/library/papers/21085181 | PubMed |
| 3 | 34849495 | The emergence of powerful oral anti-COVID-19 drugs in the post-vaccine era. | Lancet Microbe | 2022 | https://conductscience.org/library/papers/34849495 | PubMed |
| 4 | 33972410 | 2'-O methylation of RNA cap in SARS-CoV-2 captured by serial crystallography. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/33972410 | PubMed |
| 5 | 27712628 | The Nonstructural Proteins Directing Coronavirus RNA Synthesis and Processing. | Adv Virus Res | 2016 | https://conductscience.org/library/papers/27712628 | PubMed |
| 6 | 26921194 | Interaction of antihistaminic drugs with human translationally controlled tumor protein (TCTP) as novel approach for differentiation therapy. | Oncotarget | 2016 | https://conductscience.org/library/papers/26921194 | PubMed |
| 7 | 32994211 | High-resolution structures of the SARS-CoV-2 2'-O-methyltransferase reveal strategies for structure-based inhibitor design. | Sci Signal | 2020 | https://conductscience.org/library/papers/32994211 | PubMed |
| 8 | 35479715 | Natural coumarins as potential anti-SARS-CoV-2 agents supported by docking analysis. | RSC Adv | 2021 | https://conductscience.org/library/papers/35479715 | PubMed |
| 9 | 20699222 | Molecular mapping of the RNA Cap 2'-O-methyltransferase activation interface between severe acute respiratory syndrome coronavirus nsp10 and nsp16. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20699222 | PubMed |
| 10 | 23586066 | Review on natural coumarin lead compounds for their pharmacological activity. | Biomed Res Int | 2013 | https://conductscience.org/library/papers/23586066 | PubMed |
| 11 | 26958916 | Continuous and Discontinuous RNA Synthesis in Coronaviruses. | Annu Rev Virol | 2015 | https://conductscience.org/library/papers/26958916 | PubMed |
| 12 | 32091533 | Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. | JAMA | 2020 | https://conductscience.org/library/papers/32091533 | PubMed |
| 13 | 33431011 | Review on natural products databases: where to find data in 2020. | J Cheminform | 2020 | https://conductscience.org/library/papers/33431011 | PubMed |
| 14 | 32162523 | Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. | J Nat Prod | 2020 | https://conductscience.org/library/papers/32162523 | PubMed |
| 15 | 32709887 | Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin. | Nat Commun | 2020 | https://conductscience.org/library/papers/32709887 | PubMed |
| 16 | 21812660 | Molecular interaction studies using microscale thermophoresis. | Assay Drug Dev Technol | 2011 | https://conductscience.org/library/papers/21812660 | PubMed |
| 17 | 31950516 | Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. | J Med Virol | 2020 | https://conductscience.org/library/papers/31950516 | PubMed |
| 18 | 32305533 | The socio-economic implications of the coronavirus pandemic (COVID-19): A review. | Int J Surg | 2020 | https://conductscience.org/library/papers/32305533 | PubMed |
| 19 | 32226286 | Zoonotic origins of human coronaviruses. | Int J Biol Sci | 2020 | https://conductscience.org/library/papers/32226286 | PubMed |
| 20 | 35118917 | Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19:a meta-analysis. | Ann Med | 2022 | https://conductscience.org/library/papers/35118917 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42811620 | Hitting Coronaviruses Where It Hurts: Antiviral Strategies Targeting Viral Proteins. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42811620 | PubMed |
| 42171910 | The capping arms race: evolutionary interplay between IFIT proteins and viral molecular mimicry. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42171910 | PubMed |
| 41691080 | Kinic index: an artificial intelligence-driven predictive model and multitarget drug discovery framework for hepatocellular carcinoma patients. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/41691080 | PubMed |
| 41568342 | S‑Adenosylhomocysteine Analogs Selectively Suppress Pan-Coronavirus Replication by Inhibition of nsp14 Methyltransferase. | ACS Med Chem Lett | 2026 | https://conductscience.org/library/papers/41568342 | PubMed |
| 41459503 | Integrative bulk and single-cell transcriptome analyses reveal integrated stress response-related biomarkers in periodontitis with experimental validation. | Front Immunol | 2025 | https://conductscience.org/library/papers/41459503 | PubMed |
| 39258386 | Structural Basis for Inhibition of the SARS-CoV-2 nsp16 by Substrate-Based Dual Site Inhibitors. | ChemMedChem | 2024 | https://conductscience.org/library/papers/39258386 | PubMed |
| 37634741 | Coronavirus 2'-O-methyltransferase: A promising therapeutic target. | Virus Res | 2023 | https://conductscience.org/library/papers/37634741 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CAP1 | 10487 | PubTator's text mining | https://conductscience.org/library/genes/10487 | NCBI Gene |
| SH2D3A | 10045 | PubTator's text mining | https://conductscience.org/library/genes/10045 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36770656
GET https://conductscience.org/api/papers/v1/36770656/references?page=2